DiaSorin, IT0003497168

DiaSorin chart levels and sector backdrop, shares in a cautious diagnostics peer comparison

Published on 06/28/2026 at 09:45 | Editorial responsibility: Rafael MĂŒller, Editor-in-Chief AD HOC NEWS

DiaSorin opens the week with a muted share performance in European diagnostics. Investors look at key chart levels on the Milan listing and compare the stock with peers like Roche and bioMérieux.

DiaSorin, IT0003497168, Illustration mit AI erstellt.
DiaSorin, IT0003497168, Illustration mit AI erstellt.

By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-28, 09:45.

DiaSorin (IT0003497168) starts the new week with a focus on its technical picture on Borsa Italiana. The diagnostics specialist trades in a cautious range as investors compare the shares with European peers Roche and bioMérieux.

DiaSorin on Borsa Italiana

DiaSorin is listed on Euronext Milan, the main Italian equity market, and forms part of the FTSE Italia Mid Cap segment. The company belongs to the healthcare and diagnostics sector, alongside larger European players such as Roche and Siemens Healthineers.

According to recent exchange data, DiaSorin shares trade in euros, with daily liquidity typical for a mid cap healthcare stock on the Milan venue. The stock’s volatility reflects a mix of sector sentiment and company specific expectations on molecular diagnostics demand.

Sector comparison with Roche and peers

European diagnostics stocks like Roche and bioMĂ©rieux provide a benchmark for DiaSorin’s valuation and performance. Roche shares on SIX Swiss Exchange represent a large cap healthcare reference, while bioMĂ©rieux on Euronext Paris offers another mid cap comparator in laboratory diagnostics.

Analyst and market commentary on the diagnostics space often highlight pricing pressure and post pandemic normalization of testing volumes. This environment shapes investor expectations for DiaSorin’s revenue trends and margins in immunodiagnostics and molecular testing.

Go deeper

Background and price data on DiaSorin

Further corporate releases and price data on DiaSorin give investors more context on the diagnostics group’s strategy and the shares on Euronext Milan.

How DiaSorin makes its money

DiaSorin generates most of its revenues from in vitro diagnostic solutions, including immunodiagnostic and molecular diagnostic tests for clinical laboratories. The group’s platforms support routine testing in areas such as infectious diseases, oncology markers and endocrinology.

Where DiaSorin shares trade today

The DiaSorin shares (IT0003497168) trade on Euronext Milan in euros, with the current price and market capitalization reported by the Italian exchange and financial data providers as of the latest trading session.

DiaSorin at a glance

  • Company: DiaSorin S.p.A.
  • ISIN: IT0003497168
  • WKN: 778547
  • Ticker: DIA
  • Trading venue: Euronext Milan
  • Price (as of 2026-06-26, 17:30): 94.50 EUR
  • Market cap: 5.30 billion EUR (as of 2026-06-26)
  • Sector / industry: Healthcare, in vitro diagnostics
  • Index membership: FTSE Italia Mid Cap
  • Next earnings date: 2026-07-30

More on the DiaSorin shares in social media

Disclaimer: This article provides factual information on DiaSorin and its shares and does not constitute investment advice, a recommendation to buy or sell, or a forecast of future price movements.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | IT0003497168 | DIASORIN | boerse | 69644852 | bgmi